Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed director

Citius Pharmaceuticals, Inc. (CTXR) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2023 4 MCGRATH DENNIS M (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 75,000 options to buy @ $1.42, valued at $106.5k
02/09/2023 3 MCGRATH DENNIS M (Director) has filed a Form 3 on Citius Pharmaceuticals, Inc.
11/15/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 HOLUBIAK MYRON Z (Vice Chairman) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 400,000 options to buy @ $1.25, valued at $500k
10/06/2022 4 Mazur Leonard L (Executive Chairman) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 550,000 options to buy @ $1.25, valued at $687.5k
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 SAFIR HOWARD (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 75,000 options to buy @ $1.25, valued at $93.8k
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2021 4 HOLUBIAK MYRON Z (President and CEO) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 650,000 options to buy @ $2.04, valued at $1.3M
Granted 15,000 options to buy @ $2.04, valued at $30.6k
10/13/2021 4 Mazur Leonard L (Executive Chairman) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 650,000 options to buy @ $2.04, valued at $1.3M
10/13/2021 4 Webb Carol (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 75,000 options to buy @ $2.04, valued at $153k
10/13/2021 4 Bartushak Jaime (CFO) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 300,000 options to buy @ $2.04, valued at $612k
10/13/2021 4 SAFIR HOWARD (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 75,000 options to buy @ $2.04, valued at $153k
10/13/2021 4 Holuka Eugene Myron (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 75,000 options to buy @ $2.04, valued at $153k
10/13/2021 4 Dutia Suren G (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 75,000 options to buy @ $2.04, valued at $153k
10/13/2021 4 Czuczman Myron (Chief Medical Officer) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 300,000 options to buy @ $2.04, valued at $612k
10/13/2021 4 Kane William (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 75,000 options to buy @ $2.04, valued at $153k
07/26/2021 4 Kane William (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $2, valued at $30k
07/26/2021 4 Dutia Suren G (Director) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $2, valued at $30k
07/26/2021 4 HOLUBIAK MYRON Z (President and CEO) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 300,000 options to buy @ $2, valued at $600k
Granted 10,000 options to buy @ $2, valued at $20k
07/26/2021 4 Mazur Leonard L (Executive Chairman) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 300,000 options to buy @ $2, valued at $600k
07/26/2021 4 Bartushak Jaime (CFO) has filed a Form 4 on Citius Pharmaceuticals, Inc.
Txns: Granted 100,000 options to buy @ $2, valued at $200k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy